Literature DB >> 9697329

Is the Beck Depression Inventory reliable over time? An evaluation of multiple test-retest reliability in a nonclinical college student sample.

G W Ahava1, C Iannone, L Grebstein, J Schirling.   

Abstract

The Beck Depression Inventory (BDI) is one of the most widely used measures of depression. Many studies have examined the reliability and validity of the BDI. However, we found no published studies that considered the stability of the BDI over multiple administrations (i.e., more than 3 trials), such as is common in clinical trials research and during some clinical interventions. The purpose of this study is to examine the multiple test-retest reliability of the BDI in a presumably nonclinical sample. Results show a 40% decline in BDI scores over 8 weeks, a main effect that accounts for approximately 10% of the variance. We achieved a 40% decrease in self-reported symptoms of depression due to repeated measurement alone, not due to any intervention. This change likely represents measurement error with this instrument rather than any "real" change in depression. The limitations of this study, its implications for research, and its applications to clinical practice are discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9697329     DOI: 10.1207/s15327752jpa7002_3

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  4 in total

1.  Design and methods for a pilot randomized clinical trial involving exercise and behavioral activation to treat comorbid type 2 diabetes and major depressive disorder.

Authors:  Kristin L Schneider; Sherry L Pagoto; Barbara Handschin; Emily Panza; Susan Bakke; Qin Liu; Mihaela Blendea; Ira S Ockene; Yunsheng Ma
Journal:  Ment Health Phys Act       Date:  2011-06-01

2.  A psychometric evaluation of the panic disorder severity scale for children and adolescents.

Authors:  R Meredith Elkins; Donna B Pincus; Jonathan S Comer
Journal:  Psychol Assess       Date:  2013-12-02

3.  Smoking abstinence symptoms across 67 days compared with randomized controls-Moderation by nicotine replacement therapy, bupropion, and negative-affect traits.

Authors:  David G Gilbert; Norka E Rabinovich; Elizabeth A Gilbert-Matuskowitz; Keith P Klein; Michele L Pergadia
Journal:  Exp Clin Psychopharmacol       Date:  2019-03-28       Impact factor: 3.492

4.  The Greek translation of the symptoms rating scale for depression and anxiety: preliminary results of the validation study.

Authors:  Konstantinos N Fountoulakis; Apostolos Iacovides; Soula Kleanthous; Stavros Samolis; Kyriakos Gougoulias; George St Kaprinis; Per Bech
Journal:  BMC Psychiatry       Date:  2003-12-10       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.